126 related articles for article (PubMed ID: 14723386)
1. Penicillin resistance in viridans streptococcal bacteremia is related with high mortality.
Docze A; Mraz M; Grey E; Bucko E; Korcova J; Svetlansky I; Sabo Z; Krcméry V
Scand J Infect Dis; 2003; 35(11-12):916-7. PubMed ID: 14723386
[No Abstract] [Full Text] [Related]
2. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.
Husain E; Whitehead S; Castell A; Thomas EE; Speert DP
Pediatr Infect Dis J; 2005 Jun; 24(6):563-6. PubMed ID: 15933573
[TBL] [Abstract][Full Text] [Related]
3. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
[TBL] [Abstract][Full Text] [Related]
4. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
5. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
Fujitani S; Rowlinson MC; George WL
Clin Infect Dis; 2008 Apr; 46(7):1064-6. PubMed ID: 18444825
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin resistance in viridans streptococci bacteremia is clinically significant.
Grey E; Mraz M; Docze A; Korcova J; Bucko E; Krcmery V
Chemotherapy; 2007; 53(1):42-3. PubMed ID: 17202810
[No Abstract] [Full Text] [Related]
9. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
10. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
[TBL] [Abstract][Full Text] [Related]
11. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
12. Resistance to penicillin and erythromycin in viridans streptococcal bloodstream isolates from cancer and non-cancer patients within 10 years.
Ondrusova A; Liskova A; Miklosko J; Babela R; Krcmery V
Infect Control Hosp Epidemiol; 2004 May; 25(5):365-7. PubMed ID: 15188839
[No Abstract] [Full Text] [Related]
13. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci.
Yap RL; Mermel LA; Maglio J
Infection; 2006 Dec; 34(6):339-41. PubMed ID: 17180589
[TBL] [Abstract][Full Text] [Related]
15. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
16. Microbiology and clinical characteristics of viridans group streptococci in patients with cancer.
Guerrero-Del-Cueto F; Ibanes-Gutiérrez C; Velázquez-Acosta C; Cornejo-Juárez P; Vilar-Compte D
Braz J Infect Dis; 2018; 22(4):323-327. PubMed ID: 30025903
[TBL] [Abstract][Full Text] [Related]
17. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
BMC Infect Dis; 2013 Jun; 13():273. PubMed ID: 23773209
[TBL] [Abstract][Full Text] [Related]
19. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
[TBL] [Abstract][Full Text] [Related]
20. Alpha-hemolytic streptococcal bacteremia: a review of 203 episodes during 1980-1991.
Watanakunakorn C; Pantelakis J
Scand J Infect Dis; 1993; 25(4):403-8. PubMed ID: 8248738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
